New Data Demonstrates KarXT's Positive Long-Term Metabolic P

Learn more about the latest data on KarXT, which is posed to be the first new pharmacological treatment for schizophrenia.

Related Keywords

Italy , Goodideas Adobestock , Roland Chen , Bristol Myers Squibb , Drug Administration , Schizophrenia International Research Society , Annual Congress , Segal Trials , Bristol Myers , Myers Squibb , Schizophrenia International Research ,